Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
2021 Q1
12 of 25 quarters
Total Value
$113.0K
Total Shares
2.7K
Net Share Change
-12.5K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Maverick Capital
$113.0K
2.7K
0.0%
TRIM
-12.5K
(-82.1%)
Maverick Capital
$113.0K
2.7K shares
TRIM
-12.5K
(-82.1%)
HALO — Halozyme Therapeutics Inc - FilingSpy